Malvern, PA (PRWEB) June 10, 2021 HMP Global, the leading healthcare event and education company, today announced the multi-topic, specialized agenda for
Lilly s donanemab slowed Alzheimer s disease progression in Phase 2 trial: full data presented at AD/PD™ 2021 and published in NEJM prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.